REG - MyHealthChecked PLC - Posting of Circular

MyhealthcheckedAnnouncement

01/02/2021 14:05

RNS Number : 5891N
  
MyHealthChecked PLC
  
01 February 2021
  
 

 
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED.  ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.
 
MyHealthChecked plc
("MyHealthChecked" or "the Company")
 
Posting of Circular
 
Further to the announcement of 29 January 2021, MyHealthChecked plc (AIM: MHC), the consumer home-testing healthcare company, confirms it has today posted a circular to shareholders, which explains the background to and reasons for the Fundraising. The Circular contains the Notice of General Meeting to be held on 18 February 2021. A copy of the Circular and Notice of General Meeting is available on the Company's website: www.myhealthcheckedplc.com
 
Capitalised terms not otherwise defined in this announcement shall have the same meaning ascribed to such terms in the announcement released on 29 January 2021 unless the context requires otherwise.
 
For further information please contact:
 
 



MyHealthChecked plc


www.myhealthcheckedplc.com




Penny McCormick, Chief Executive Officer


via Walbrook PR




Maddy Kennedy, Chief Financial Officer


















SPARK Advisory Partners Limited (NOMAD)


Tel: +44 (0)20 3368 3550




Neil Baldwin 


















Oberon Investments  (Broker)


Tel: +44 (0)203 179 5344




Mike Seabrook


mikeseabrook@oberoninvestments.com














Walbrook PR Ltd (Media & Investor Relations)


Tel: +44 (0)20 7933 8780 or myhealthcheckedplc@walbrookpr.com




Paul McManus


Mob: +44(0)7980 541 893 



 
 
 
 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
MSCUPUUUPUPGGCG